Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $173M (100.0% shares, 0.0% debt)

Holdings (19)

— Biohaven Pharmactl Hldg Co L 35.8%

Value $62.07M Shares 857,494 Est. Cost $27.10 Unrealized —

— Corbus Pharmaceuticals HLDGS 24.4%

Value $42.34M Shares 5,045,870 Est. Cost $4.99 Unrealized —

— Applied Therapeutics Inc 13.3%

Value $22.99M Shares 650,238 Est. Cost $15.16 Unrealized —

— Abeona Therapeutics Inc 4.7%

Value $8.15M Shares 2,859,767 Est. Cost $4.67 Unrealized —

— Orgenesis, Inc. 4.6%

Value $8.003M Shares 1,316,364 Est. Cost $6.08 Unrealized —

— Eiger Biopharmaceuticals Inc 2.9%

Value $5.063M Shares 525,238 Est. Cost $9.50 Unrealized —

AVXL Anavex Life Sciences Corp 2.1%

Value $3.621M Shares 724,205 Est. Cost $3.56 Unrealized +6.1%

— Exicure Inc 1.8%

Value $3.067M Shares 1,277,777 Est. Cost $2.86 Unrealized —

ENTX Entera Bio Ltd 1.7%

Value $3.013M Shares 1,741,363 Est. Cost $3.39 Unrealized -39.8%

ALDX Aldeyra Therapeutics Inc 1.4%

Value $2.374M Shares 569,405 Est. Cost $8.37 Unrealized -56.3%

— Blackstone Group LP 1.3%

Value $2.246M Shares 40,000 Est. Cost $34.97 Unrealized —

— Centurylink Inc 1.3%

Value $2.171M Shares 220,000 Est. Cost $12.48 Unrealized —

— Soligenix Inc. 0.9%

Value $1.584M Shares 787,830 Est. Cost $2.11 Unrealized —

— Molecular Templates 0.9%

Value $1.54M Shares 113,905 Est. Cost $4.04 Unrealized —

DOW Dow Inc 0.7%

Value $1.223M Shares 30,000 Est. Cost $36.37 Unrealized -26.2%

— Catasys Inc 0.6%

Value $1.097M Shares 43,034 Est. Cost $16.93 Unrealized —

— BioXCel Therapeutics Inc 0.6%

Value $1.07M Shares 20,000 Est. Cost $22.35 Unrealized —

CTVA Corteva Inc 0.5%

Value $811K Shares 30,000 Est. Cost $25.02 Unrealized -2.7%

DD Dupont de Nemours Inc 0.5%

Value $785K Shares 15,000 Est. Cost $27.24 Unrealized -36.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmactl Hldg Co L	857,494	$62.07M	35.8%	$27.10	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	5,045,870	$42.34M	24.4%	$4.99	—	COM	21833P103
—	Applied Therapeutics Inc	650,238	$22.99M	13.3%	$15.16	—	COM	03828A101
—	Abeona Therapeutics Inc	2,859,767	$8.15M	4.7%	$4.67	—	COM	00289Y107
—	Orgenesis, Inc.	1,316,364	$8.003M	4.6%	$6.08	—	COM	68619K105
—	Eiger Biopharmaceuticals Inc	525,238	$5.063M	2.9%	$9.50	—	COM	28249U105
AVXL	Anavex Life Sciences Corp	724,205	$3.621M	2.1%	$3.56	+6.1%	COM NEW	032797300
—	Exicure Inc	1,277,777	$3.067M	1.8%	$2.86	—	COM	30205M101
ENTX	Entera Bio Ltd	1,741,363	$3.013M	1.7%	$3.39	-39.8%	SHS	M40527109
ALDX	Aldeyra Therapeutics Inc	569,405	$2.374M	1.4%	$8.37	-56.3%	COM	01438T106
—	Blackstone Group LP	40,000	$2.246M	1.3%	$34.97	—	COM UNIT LTD	09253U108
—	Centurylink Inc	220,000	$2.171M	1.3%	$12.48	—	COM	156700106
—	Soligenix Inc.	787,830	$1.584M	0.9%	$2.11	—	COM	834223307
—	Molecular Templates	113,905	$1.54M	0.9%	$4.04	—	COM	608550109
DOW	Dow Inc	30,000	$1.223M	0.7%	$36.37	-26.2%	COM	260557103
—	Catasys Inc	43,034	$1.097M	0.6%	$16.93	—	COM PAR	149049504
—	BioXCel Therapeutics Inc	20,000	$1.07M	0.6%	$22.35	—	COM	09075P105
CTVA	Corteva Inc	30,000	$811K	0.5%	$25.02	-2.7%	COM	22052L104
DD	Dupont de Nemours Inc	15,000	$785K	0.5%	$27.24	-36.0%	COM	26614N102